Company

Scinai Immunotherapeutics Ltd.

Biotechnology Research Il 32 employees SCNI

Employees: 32
Contacts: 3
Emails: 3
Phones: 1

biondvax.com LinkedIn Crunchbase

Scinai Immunotherapeutics Ltd. Overview

Headquarters: Il
Website: biondvax.com
Industry: Biotechnology Research
Employees: 32
Stock Symbol: SCNI
Funding: 1.4M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

BiondVax Biotechnology Recombinant Proteins Clinical Trials Nasdaq Infectious diseases Pharmaceutical Pharmaceutical Manufacturing GMP GXP Therapeutics nanobodies

About Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs. Company website: www.scinai.com

Scinai Immunotherapeutics Ltd. Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Scinai Immunotherapeutics Ltd. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Adi Raviv	Ceo/coo/cfo/board Member - Chair Audit	New York, United States	Email
Tamar Ben-Yedidia	Chief Scientific Officer & Clinical	West Jerusalem, Jerusalem District, Israel	Email Phone
Solomon Gahtan	Director Cdmo Bd & Sales, Biotechnology		View
Chana Sternberg Rn , Bsn, M.occ. H	CEO & Founder @Csc - Clinical Trial	Shoham, Center District, Israel	Email